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.2012.08.Abstract Background: Allogeneic blood transfusion increases the incidence of tumor recurrence
and affects survival of patients undergoing liver resection. Acute normovolemic heamodilution
(ANH) helps to decrease the exposure to allogeneic transfusion. This technique in cirrhotic patients
undergoing major liver resection may compromise the coagulation process. Study of coagulation
effects of ANH using rotation thromboelastometry (ROTEM), which provides global evaluation
of coagulation function, may add beneﬁcial effects.
Patients and methods: 160 ASAII, Child A cirrhotic patients undergoing major hepatic resection
were prospectively randomized into two equal groups; control and ANH group in which ANH
was done. ROTEM (extem and ﬁbtem) and conventional coagulation tests (CCT) (INR, ﬁbrinogen
level, and platelet count), were measured at baseline, 1 h after start of surgery, at the end of surgery
and on 3rd and 5th postoperative days. Also blood lactate level and oxygen consumption were eval-
uated at the previous measuring points. The number of patients received allogeneic blood transfu-
sion and the amount of blood received blood loss, ﬂuid infused were recorded.
Results: ROTEM parameters of ANH group showed statistically signiﬁcant changes compared to
base line value and corresponding control values at 1 h after surgery. These changes were slightly
outside the normal range, 1 h after surgery and within the normal reference range in all the follow-
ing study points. Conventional coagulation parameters had the same pattern of changes but values
were outside normal range all over the study period. ANH decreased the incidence of allogeneic
packed red blood cell transfusion by 22.5% (28.75% vs. 6.25% of patients received packed red
blood cells in control and ANH groups respectively) and plasma transfusion by 6.25% (13.75%rtment of Anesthesia, National
ypt. Tel.: +20 1113320976.
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54 N.A. Fayed et al.vs. 7.5% of patients received plasma in control vs. ANH group respectively). No reported compli-
cations related to ANH were detected.
Conclusion: ROTEM added two beneﬁts 1st it gave some clinical evidence of safety of ANH asso-
ciated coagulation changes which may encourage more degree of haemodilution in this category of
patients. Second the use of ROTEM triggered transfusion parameters seemed to help decrease
plasma transfusion requirement which serves the aim of ANH.
ª 2012 Egyptian Society of Anesthesiologists. Production and hosting by Elsevier B.V.
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The reported rate of allogenic blood transfusion during liver
resection varies between centers [1,2]. Allogenic blood transfu-
sion has been associated with an increased incidence of tumor
recurrence and decreased survival [3,4] and its avoidance in
both cirrhotic and non-cirrhotic patients undergoing liver
resection improves survival [5]. Heamodilution has been found
as an effective method to decrease intraoperative exposure to
allogeneic blood [6]. Hepatic patients are known to have dis-
turbed coagulation proﬁle [7] which would be further disturbed
by liver resection surgery with more coagulation derangement
[8]. In such situation critical hemostatic levels can become the
primary transfusion triggers [9]. In this condition assessment of
coagulation changes is mandatory to ensure safety of heamod-
ilution in this category of patients.
Traditionally, evaluation of coagulopathy has been based
largely on the platelet poor plasma assessment of the extrinsic
and intrinsic pathways which reﬂects <5% of the thrombin
generated during clot formation [10]. Previous clinical studies
found that up to 35% of the variability in the INR and 20%
of the variability of the PTT are unrelated to underlying clot-
ting factor levels [11]. Coagulation research has been redirected
to the cell-model of hemostasis, recognizing the central role of
platelets, the endothelium, and their interaction with the plas-
ma elements [12]. Thromboelastometry (ROTEM; Tem
International GmbH, Munich, Germany) offers rapid, com-
prehensive, global, clinical assessment of the patient’s coagula-
tion status, from initiation of coagulation to the formation,
quality and potential breakdown of the clot [13,14]. ROTEM
test results have also been used to guide coagulation therapy
[15,16].
We therefore hypothesized that using ROTEM as a com-
prehensive assessment of clot integrity may reﬂect an evidence
of safety of ANH associated coagulation changes in this cate-
gory of patients undergoing such operation.
2. Patients and methods
After approval of the local ethical committee and written in-
formed consent, 160 ASAII patients with Child A cirrhosis
undergoing major liver resection (> or =3 segments) were
prospectively randomized studied. Exclusion criteria included
signiﬁcant history of cerebrovascular disease, cardiovascular
disease, pulmonary disease, renal dysfunction (creatinine
P1.5 mg/dL), platelet count <100,000, presence of active
infection, evidence of hepatic metabolic disorder (bilirubin
>2 mg/dL or ALT >75 U/L), drug therapy affecting coagula-
tion within 14 day before and preoperative hemoglobin less
than 11gm/dl. Patients were divided randomly into two
groups; ANH group (n= 80) in which patients underwentANH and control group (n= 80), without ANH. After stan-
dard monitoring had been placed, anesthesia was induced
using propofol 2 mg/kg and 0.9 mg/kg rocuronium to facilitate
endotracheal intubation. Anaesthesia was maintained with iso-
ﬂurane in O2: air mixture (FiO2 = 0.4), fentanyl , and rocuro-
nium keeping entropy reading between 40% and 60%. Two
wide bore peripheral venous cannulae , an arterial line , and
central line were inserted. For ANH group, hemodilution pro-
cess was initiated immediately after tracheal intubation via the
internal jugular catheter to a target Hematocrit of 27%. the
allowable blood withdrawn was determined using the estab-
lished formula: VL = EBV \H0 – HF/HAV, where VL is the
allowable blood loss, EBV is the estimated blood volume,
H0 is the patient’s initial Hgb, HF is the patient’s minimal
allowable Hgb, and HAV is the average of the initial and min-
imal allowable Hgb.12,19,20. The blood, removed into stan-
dard citrate–phosphate–dextrose adenine blood storage bags,
was simultaneously replaced by equal volume of 6% hydroxyl
ethyl starch 130/0.4 (HES 130/0.4).
Transfusion threshold for erythrocytes was hematocrit less
than 24%. Haemostatic products are transfused using RO-
TEM based protocol, shown in the index [17]. Autologous
blood was reinfused when a target hematocrit value was
reached or after completion of liver resection and hemostasis,
in the reverse order of collection.
All Patients received Ringer’s acetate: 6 ml/kg/h as a con-
tinuous infusion. Intraoperative ﬂuid optimization managed
by the Cardio Q_ oesophageal Doppler monitor (ODM) using
the following protocol adopted by Sinclair and colleagues [18].
For patients with a FTc less than 350 ms, suggesting hypo-
volaemia, the protocol consisted of a ﬂuid challenge HES 130/
0.4 (3 ml/kg) over 5–10 min.
There were three possible outcomes:
(i) SV same or increased, FTc <350 ms––repeat ﬂuid
challenge;
(ii) SV increases by >10%, FTc >350 ms––repeat ﬂuid
challenge till no increase in SV; and
(iii) FTc > 400 ms––no further ﬂuid till FTc or SV decreased
by 10%.
Invasive blood pressure, heart rate, central venous pressure
(CVP), arterial oxygen saturation, end tidal CO2 tension and
esophageal temperature were monitored continuously. INR,
ﬁbrinogen level, platelet count, and ROTEM extem CFT,
MCF, alpha angle and ﬁbtem MCF were done preoperative
as base line, 1 h after start of surgery , at the end of surgery,
and 3rd and 5th postoperative days. ODM parameters include
including cardiac output, corrected ﬂow time, systemic vascu-
lar resistance, Oxygen consumption and Serum lactate were re-
corded; base line, 1 h after start of surgery and at end of
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products administered were recorded. Liver and kidney func-
tion tests were done at base line and on postoperative day 1, 3.
3. Statistical procedure
Data was statistically analyzed using SPSS (statistical package
for social science) program version 13 for windows for all the
analysis a p value < 0.05 was considered statistically signiﬁ-
cant: – data are shown as mean, range or value and 95% con-
ﬁdence interval (95% CI) and frequency and percent. All data
are tested with Kolmogorov-Smirnov Z test and most of them
were found normally distributed and so presented with
mean ± SD. And using both parametric and non-parametric
testes on doing associations. Repeated measures ANOVA test
was performed to differentiate changes in different follow up
results of normally distributed studied variables.
4. Results
Patient’s data and clinical characteristics given in (Table 1).
There were 3 patient in control and 5 in ANH group with pre-
operatively controlled hypertension and 4 patients of type II
diabetes on oral hypoglycemic treatment 2 in each group.
There were no statistically signiﬁcant hemodynamic differ-
ences between both groups at all measuring points. However
the hemodynamics in both groups changed signiﬁcantly com-
pared to base line after resection and towards the end of sur-
gery (Table 2).
Regarding allogeneic transfusion requirement 5 out of 80
patients in ANH group required packed red blood cell unites
compared to 23 out of 80 patients in control group also plasma
transfusion showed statistically signiﬁcant decrease in ANH
group 6/80 compared to control group 11/80 (Table 3). None
of both groups received platelets or cryoprecipitate.
ROTEM parameters showed statistically signiﬁcant change
compared to base line in ANH, 1 h after start of surgery and at
end of surgery while control group showed statistically signif-
icant difference only at the end of surgery compared to the
base line. The comparison between both groups showed statis-
tically signiﬁcant difference 1 h after surgery and no signiﬁcantTable 1 Patients clinical characteristics.
Studied variables A
Age (years) 50
Weight (kg) 71
Height (cm) 16
Gender (M/F) 65
Operation time (min) 30
Volume of blood withdrawn (ml) 17
Initial HCT (%) 40
Final HCT (%) 30
Estimated blood loss (ml) 12
Intraop urine output (ml) 91
Intraoperative ﬂuids (ml) 50
Colloids (ml) 27
Crystalloids (ml) 22
RLV (%) 39
Values are mean ± SD, ANH= acute normovolemic hemodilution, RL
* Denotes statistical signiﬁcant between both groups.change between both groups after that. Almost all studied RO-
TEM parameters were within normal range values (apart from
slight changes at 1 h after surgery in ANH group) (Table 4).
CCT parameters showed the same pattern of changes in both
groups when compared to base line values and when compared
to each other but the values were outside the normal range val-
ues (Table 5). There was signiﬁcant increase in lactate level
compared to base line in both groups while the there was no
signiﬁcant differences between both groups at all measuring
points. Oxygen consumption showed signiﬁcant reduction in
both groups compared to base line values and the comparison
of both groups was insigniﬁcant (Table 6). All patients were
extubated at the end of surgery in the operation room except
5 patients (2in control and 3 in ANH GROUP) who were extu-
bated within 4 h in surgical ICU. One patient in control group
suffered from postoperative bleeding due to surgical causes
and re-explored.
5. Discussion
The challenge in this study was the disturbed coagulation pro-
ﬁle of cirrhotic patients which was further stressed by both
ANH and liver resection hence critical haemostatic levels
may become the primary transfusion triggers. Singbartl et al.
[9] demonstrated that in normal volunteers during profound
haemodilution, haemostasis disturbed before the supply of
oxygen to tissues, i.e., the limiting factor for haemodilution
would be the changes in haemostasis caused by dilution of
platelets and coagulation factors. Although we followed milder
degree of haemodilution compared to Singbartl et al., the com-
promised coagulation reserve of cirrhotic patients and the ef-
fect of liver resection may impair the haemostatic process to
a critical level that makes it logic to seek for a more ﬁrm proof
of safety of this maneuver in such operation.
ROTEM has gained wide acceptance for monitoring of ac-
quired perioperative coagulopathy and compared with PT/PTI
and aPTT, thrombelastometry yields additional information
regarding clot ﬁrmness and stability [19,20]. On the other
hand, INR and PTT failed to correlate with clinical bleeding
[21,22] and were not sensitive in detecting coagulation defects,
compared with TEG which differentiated the mechanism re-NH (N= 80) Control (n= 80)
± 6 48.5 ± 1
± 12 69 ± 12
0 ± 4 159 ± 4.67
/15 60/20
2 ± 54 286 ± 44
50 ± 550 0
.82 ± 2.94 41.11 ± 3.21
.55 ± 3.31 29.55 ± 2.88
40 ± 776 1322 ± 834
9 ± 651 833 ± 604
11 ± 1340* 3486 ± 1344
18 ± 526* 1294 ± 415
93 ± 736 2152 ± 799
.5 ± 4.6 39 ± 4.8
V%= remaining liver volume %.
Table 2 Haemodynamic changes.
Baseline After haemodilution After resection End surgery
CVP (mm Hg)
ANH 7.3 ± 2.0 6.8 ± 1.7 7.2 ± 0.8 6.4 ± 1.3
Control 7.1 ± 2.1 6.7 ± 1.5 6.9 ± 1.1 6.1 ± 1.4
MAP (mm Hg)
ANH 87.33 ± 14.5 74.2 ± 11.2* 71.8 ± 10.4* 70.8 ± 11.1*
Control 88.29 ± 13.7 76.1 ± 12.4* 73.9 ± 11.2* 71.6 ± 12.3*
FTC (ms)
ANH 361 ± 16.8 369 ± 9.7 370 ± 14.6 375 ± 39
Control 365 ± 36 377 ± 45 367 ± 45 372 ± 35
COP (L/min)
ANH 5.6 ± 1.8 6.17 ± 1.5 7.15 ± 15.8* 7.5 ± 1.8*
Control 5.9 ± 1.9 6.04 ± 1.5 7.04 ± 1.5* 7.7 ± 1.9*
SVR (dynes sec/cm5)
ANH 1100 ± 355 985 ± 344 862 ± 284* 808 ± 320*
Control 1187 ± 340 1010 ± 298 850 ± 290* 790 ± 340*
No statistical signiﬁcant difference between both groups, FTC= corrected ﬂow time; COP = cardiac out put; SVR= systemic vascular
resistance; MAP= mean arterial blood pressure.
* Denoting statistically signiﬁcant difference compared to base line values (P< 0.05).
Table 3 Allogenic transfusion requirement.
ANH (n= 80) Control (n= 80)
Allogenic packed red blood cells
Number of patients (%) 5/80 (6.25) 23/80 (28.75)
Units/patient 0.7 ± 1.68* 1.55 ± 1.8
Allogenic fresh frozen plasma
Number of patients (%) 6/80 (7.5) 11/80 (13.75)
Units/patient 0.8 ± 1.64* 1.7 ± 1.95
Values are mean ± SD, ANH= acute normovolemic
hemodilution.
* Denoting statistically signiﬁcant difference (P< 0.05).
56 N.A. Fayed et al.lated to clotting abnormalities in experimental trauma and
hemorrhagic shock [23].
This study assessed ROTEM extem clot formation time
(CFT), which is the time (in seconds) until a deﬁnite clot is
formed (deﬁned as an amplitude of 20 mm), extem maximum
clot ﬁrmness (MCF; given in millimeters), which measures
the clot strength and depends primarily on platelet and ﬁbrin-
ogen function. And extem a angle that measured between the
midline of the tracing and a straight line drawn from the 1-mm
point tangential to the curve, indicates the rate of ﬁbrin poly-
merization, and ﬁbtem MCF which monitor the ﬁrmness of ﬁ-
brin clot when the contribution of platelets is removed.
These selected ROTEM parameters are are used primarily
to evaluate overall clot stability and ﬁbrin polymerization [24]
and should be performed simultaneously as ﬁrst-line ROTEM
tests in bleeding surgical patients [25]. Also, CFT andMCF are
the most interesting parameters to be considered for clinical
studies to assess bleeding-risk in cirrhotic patients [26].
In this study markers for clot strengthening (a-angle and
MCF), MCF of ﬁbtem, and extem CFT changed signiﬁcantly
after 1 h of start surgery and at end of surgery compared to
baseline with ANH. In normal healthy volunteers, TEG
parameters R, K, angle alpha, and MA changed exponentiallyand in contrast to our study it has been found that the effects
were signiﬁcant only at dilutions 60% for R, K, and angle al-
pha, while MA decreased signiﬁcantly at dilution 30% [27]. In
current study the signiﬁcant changes on ROTEM parameters
were observed at milder dilutions which may be attributed to
the type of our patients with impaired coagulation reserve.
The results of Bang et al. [28] supported this explanation as
they concluded that: haemodilution with 6% HES (130/0.4) re-
sults in TEG abnormalities even with 11% hemodilution, in
ESLD patients undergoing liver transplantation and the more
the dilution the higher the increasing in the signiﬁcance of
TEG deterioration. Kim et al. [29] stated that coagulopathy
was not observed at mild 25% or moderate 50% hemodilution,
highlighting the important functional reserve of coagulation
factors in the setting of trauma and hemorrhagic shock.
In spite of the recorded statistical signiﬁcant difference of
ROTEM parameters in ANH group, compared to their base
line values and to corresponding values of control group, after
ANH and even they were sometimes slightly outside the nor-
mal range, these changes were only indicating unimpaired hae-
mostasis with reduced reserve according to Andreas Calatzis
et al. [30] clinical interperitation of ROTEM parameters in
acute haemostatic disorders. This is in agreement with a study
by Wohlauer et al. [31] who found that hemodilution does not
have a signiﬁcant impact on coagulation and clot integrity is
maintained following ﬂuid resuscitation.
All ROTEM parameters improved at the end of surgery (all
values were within normal range) and were statistically non-
signiﬁcant compared to corresponding control values. This
may be attributed to retransfusion of the autologous blood
with its contents of coagulation factors and platlets. The 3rd
and the 5th day values were statistically insigniﬁcant compared
to control group and were within normal range. These data
came with disagreement to conventional coagulation tests
results.
On the other hand the base line values of INR were outside
the normal range in both groups and further signiﬁcantly dete-
Table 4 ROTEM parameters changes of both group.
Variable Control group ANH group P
EX CFT baseline (s) 117.15 ± 21.95 116.05 ± 23.4 0.99
EX CFT 1 h after start of surgery (s) 120.45 ± 24.86 155.0 ± 29.76* 0.019
EX CFT at end of surgery (s) 139.15 ± 25.39* 135.1 ± 23.65* 0.13
EXCFT 3rd POD 146.96 ± 21* 145.75 ± 22.78* 0.09
EX CFT 5th POD 129.81 ± 19.98* 128.98 ± 18.81* 0.08
EX MCF baseline (mm) 56.80 ± 7.56 55.45 ± 6.29 0.148
EX MCF 1 h after start of surgery (mm) 54.05 ± 6.81 48.40 ± 4.15* 0.024
EX MCF at end of surgery (mm) 45.25 ± 5.17* 46.00 ± 6.42* 0.144
EX MCF 3rd POD 55.20 ± 6.47 56.50 ± 6.76 0.26
EX MCF 5th POD 56.20 ± 7.56 57.90 ± 7.48 0.167
EX baseline a-angle () 58.20 ± 7.19 59.00 ± 8.01 0.934
EX a-angle 1 h after start of surgery () 56.35 ± 7.72 51.80 ± 7.3* 0.026
EX a-angle at end of surgery () 50.00 ± 6.91* 50.70 ± 7.67* 0.466
EX a-angle 3rd POD 59.89 ± 8.29 59.35 ± 9.19 0.58
EX a-angle 5th POD 60.89 ± 7.29 61.99 ± 8.39 0.12
FIBTEM baseline MCF (mm) 13.90 ± 2.60 14.10 ± 2.90 0.649
FIB MCF 1 h after start of surgery (mm) 12.25 ± 2.52 10.10 ± 2.21* 0.043
FIB MCF at end of surgery (mm) 9.80 ± 2.12* 10.05 ± 2.58* 0.74
FIB MCF 3rd POD 14.5 ± 3.1 14.8 ± 2.9 0.52
FIB MCF 5th POD 15.8 ± 3.9* 15.9 ± 3.4* 0.64
ANH= acute normovolaemic haemodilution.
EX = extem FIB = ﬁbtem CFT= clot formation time MCF=maximum clot ﬁrmness POD= postoperative day.
Data are presented as mean ± SD.
P indicating the signiﬁcance of comparison of both groups.
* Denotes P< 0.001 vs. corresponding baseline value.
Table 5 Conventional coagulation changes of both groups.
Variable Control Group ANH group P
Fibrinogen level 1 (mg/dl) 224.65 ± 69.50 228.55 ± 63.19 0.854
Fibrinogen level 2 (mg/dl) 213.50 ± 66.03 172.55 ± 43.79* 0.014
Fibrinogen level 3 (mg/dl) 145.75 ± 51.09* 149.9 ± 44.17* 0.365
Fibrinogen level 4 (mg/dl) 246.50 ± 49.91* 250 ± 46.23* 0.312
Fibrinogen level 5 (mg/dl) 228.25 ± 43.62 231 ± 39.91 0.225
Platelet count 1 (·103/mm3) 161.20 ± 41.80 167.55 ± 45.49 0.458
Platelet count 2 (·103/mm3) 151.40 ± 41.03 138.8 ± 37.25* 0.041
Platelet count 3 (·103/mm3) 129.85 ± 20.11* 130.4 ± 25.44* 0.320
Platelet count 4 (·103/mm3) 117 ± 23* 119 ± 21* 0.26
Platelet count 5 (·103/mm3) 124 ± 22* 129 ± 19* 0.14
INR 1 1.43 ± 0.21 1.47 ± 0.19 0.549
INR 2 1.48 ± 0.21 1.64 ± 0.16* 0.041
INR 3 2.19 ± 0.31* 2.03 ± 0.27* 0.078
INR 4 1.67 ± 0.17* 1.66 ± 0.15* 0.15
INR 5 1.54 ± 0.16 1.51 ± 0.11 0.11
1 = Base line values, 2 = values 1 h after start of surgery, 3 = values at the end of surgery,4 = postoperative day3, 5 = postoperative day5.
ANH= acute normovolemic hemodilution.
Data are presented as mean ± SD.
P indicating the signiﬁcance of comparison of both groups.
* P< 0.001 vs. corresponding baseline value.
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responding value of control group. And continue to deterio-
rate in both group at the end of surgery and did not reach
its base line value at 5th POD. This reﬂected hypocoagulability
is not of clinical signiﬁcance as the available evidence is nota-
ble for a lack of correlation between mild-to-moderate coagu-lation test abnormalities and the development of procedural
bleeding or need for red blood cell administration [32,33].
Chowdary et al. noted that nearly 50% of patients with
abnormal coagulation tests (INR >1.5) had coagulation fac-
tor levels generally considered sufﬁcient for adequate throm-
bus formation [34].
Table 6 Metabolic and laboratory changes.
Base line 1 h After surgery End surgery D1 D3
Lactate(mg/dl)
ANH 10.8 ± 5.1 17.1 ± 6.51* 22.3 ± 7.3*
Control 11.08 ± 4.82 16.8 ± 6.12 * 21.9 ± 7.4*
VO2 (ml/min/m2)
ANH 127.7 ± 25.1 91.19 ± 19.3* 88.2 ± 17.8*
Control 129.2 ± 27.8 89.8 ± 17.9* 92.4 ± 20.2*
Creatinine (mg/dl)
ANH 0.85 ± 0.23 0.83 ± 0.2 0.78 ± 0.1
Control 0.78 ± 0.1 0.85 ± 0.17 0.79 ± 0.1
Serum aminotransferase SGPT
ANH 51.03 ± 27.9 263.9* ± 18* 212.2 ± 49*
Control 54.9 ± 28.4 257.9* ± 293* 215.7 ± 57*
Values are mean ± SD D1= postoperative day1 D3 = postoperative day 3VO2 = oxygen consumption.
* P< 0.05 compared with baseline value.
58 N.A. Fayed et al.Patients in the ANH group had 22.5% reduction in the like-
lihood of requiring allogeneic blood transfusion compared to
control group. Previous studies provided strong evidence that
ANH technique effectively reduces the need for allogeneic
blood transfusions [2,7] in Patients undergoing major hepatic
resection and recommended ANH for routine use [35]. As
ANH reduces the hemoglobin (Hb) concentration of blood,
any surgical blood loss will contain relatively less Hb [36].
The efﬁcacy of ANH to decrease exposure to allogenic
blood transfusion in this study was less than that reported
by Idit Matot et al. (22.5% versus 26%) respectively, this
may be due to the higher transfusion trigger of HCT in this
study (24% versus 21%). Although our transfusion trigger
was less efﬁcacious, we have chosen this approach, following
other investigators [37] as sudden extensive bleeding may occur
with an acute and rapid decrease in Hematocrit below the low-
est acceptable value. In our study, ROTEM was used to assess
the effects of (ANH) on blood coagulation.
Fresh frozen plasma transfusion was higher in control group
suggesting that ANH is also effective in preserving coagulation
factors. Reinfusion of fresh coagulation factors and platelets is
thought to augment a patient’s inherent coagulation function
[38] as manifested by better (although non-signiﬁcant) end of
surgery ROTEM and CCT in ANH group compared to control
group.
In our study we observed that the % of plasma transfusion
in both groups (7.5% and 13.75% in ANH and control group
respectively) was lower than that recorded by Jarnagin et al. [2]
(17.5% and 28.4% in ANH and control groups respectively).
Actually William et al. depended on INR >1.8 as a trigger
for plasma transfusion while we depended on ROTEM triggers
together with clinical assessment of the surgical ﬁeld. It has
been found that PT and aPTT are not good for orientating
the decision and indication of transfusion of blood products
[39]. On the other hand thromboelastography-guided transfu-
sion decreases transfusion plasma in liver transplantation
[40] and aortic arch replacement [41].
In ANH group, the mean volume of collected blood was
1750 ± 550 ml. Feldman et al. [42] found that, withdrawal of
more than 1000 ml, blood during ANH is accompanied with
signiﬁcant reduction in the likelihood of transfusion.The overall mean surgical blood loss in ANH group was
lower but statistically insigniﬁcant compared with control
group which comes in agreement with other studies [7].
In the current study, HES 6% (130/0.4) was used for
replacement during ANH. Erol and Erdogan [43] found that
ANH with HES 6% (130/0.4) did not cause any hemodynamic
or blood gas parameters changes and did not have any adverse
effect on haemostatic mechanisms that could enhance the risk
of bleeding at surgery. While in their study, Konrad et al. [44]
demonstrated that hydroxyethyl starch (HES) prolonged the
time of clot formation Similarly, Egli et al. [45] demonstrated
that HES prolonged CFT at any degree of hemodilution. In
our study coagulation parameters signiﬁcantly changed after
heamodilution but the effect of HES 6% (130/0.4) as a contrib-
uting factor cannot be conﬁrmed or ruled out as there is an-
other important factor, the hemodilution which may account
totally or in part in this effect.
This study depended on ODM for optimal ﬂuid manage-
ment and the colloid required in ANH group was signiﬁcantly
higher than control group for replacement of withdrawn
blood. Also it is used to assess intraoperative heamodynamic
changes. It seems that ANH did not affect the hemodynamic
condition of the patients as evidenced by the non-signiﬁcant
comparison between both groups. COP and SVR changes after
resection and at the end of surgery were attributed to the
hemodynamic effect of liver resection [46].
Oxygen consumption remained adequate with no statisti-
cally signiﬁcant difference between both groups and hemato-
crite kept more than 24% all over the study period. Crystal
and Salem [47] reported that patients undergoing hemodilution
to hematocrit as low as 20% can maintain oxygen supply to
tissues due to compensatory mechanisms .The improvement
of the rheological conditions may optimize tissue oxygen deliv-
ery and attenuate ischemia–reperfusion injuries [48].
Plasma lactate levels signiﬁcantly increase compared to
base line in both groups and the comparison between both
groups was insigniﬁcant which rules out the role of ANH as
a leading cause. The elevated lactate level is explained by de-
creased lactate uptake due to decreased hepatic blood ﬂow
during compression and mobilization of the liver [49]. Also,
a dose-dependent decrease in hepatic blood ﬂow induced by
Acute normovolaemic haemodilution in cirrhotic patients undergoing major liver resection: Role of ROTEM 59isoﬂurane might depress liver function signiﬁcantly in cirrhotic
patients, and thus enhance lactate accumulation [50]. There
were no adverse cardiac, renal, or neurologic outcomes with
ANH. This may be attributed to careful patient selection
and exclusion of patients with medical conditions which might
be adversely affected by hemodilution. Matot et al. reported
similar ﬁndings [6].
In conclusion ROTEM in this study added two beneﬁts 1st
it gave some clinical evidence of safety of ANH regarding asso-
ciated coagulation changes in such category of patients which
may encourage to go with HCT transfusion trigger to a lower
value. Second the use of ROTEM triggered transfusion param-
eters seemed to help decrease plasma transfusion requirement
which serves the aim of ANH.6. Index of ROTEM guided transfusion protocol
Check surgical ﬁeld if there is:
1 – Diﬀuse surgical bleeding
Check and optimize basic conditions.
(Temperature >35, ph > 7.2, Cai > 1 mmol/l, HB > 8 gm/dl)
Then if:
Extem MCF <25 mm give platelets, cryoprecipitate, FFPs
Extem MCF<45 mm and ﬁbtem MCF< 8mm.give cryprecipitate
Extem MCF <45 mm and ﬁbtem >8 mm give platelets
2 – No diﬀuse clinical bleeding
Then if:
Extem MCF >35 mm; no haemostatic therapy is indicated
Extem MCF MM <35 mm and ﬁbtem MCF <8 mm give
cryoprecipitate
Extem MCF <35 mm and ﬁbtem MCF >8 mm give platelets
3 – If Extem CT > 80 s give FFPsReferences
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